Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Fabry Disease Market (By Treatment, Route of Administration, Product, End-User, Country Analysis), Key Company Profiles, Product Portfolio, Pipeline ...
RICHMOND, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced detailed data from the registrational Phase 1/2 STAAR study ...
SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim data ...
A Chiesi survey has found widespread unmet needs among Fabry disease patients taking drugs such as Sanofi’s Fabrazyme, pointing to how the Italian drugmaker can muscle in on the market. Chiesi won FDA ...
Fabry disease runs in families. It can have lots of different symptoms, including pain in the hands and feet and a specific kind of rash. When you have Fabry disease, a certain type of fatty substance ...
Fabry disease is a rare, inherited disease caused by the deficiency of a certain enzyme that breaks down fats in the body. Typically, a lysosomal enzyme known as alpha-galactosidase A (a-GAL A) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback